Mpox outbreak study in Equateur, DR Congo
Part of Infections clinical trials.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or someone you trust must agree to join the study (oral consent is okay with a witness).
- You must have a rash with deep, firm blisters or pustules that looks like mpox.
- You must have at least one of these: fever before the rash, swollen lymph nodes (in groin, armpit, or neck), or pustules on your palms or soles.
- A lab test (like a PCR test) must confirm you have mpox.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
This study tests whether a single dose of the LC16m8 mpox vaccine is safe and works in people living in the Democratic Republic of Congo. It also monitors for side effects and tracks mpox cases to see how well the vaccine protects the community.
This study follows people with mpox and their close contacts in Guinea to learn how the virus spreads and to measure how well the mpox vaccine works. You would be involved for up to two months and help improve prevention and care.
This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.
This study is testing a new way to diagnose mpox (formerly monkeypox) using a sample from your skin sores. If you have symptoms that look like mpox, this test might help confirm the diagnosis quickly.
This study looks at how well your immune system remembers the mpox virus after you've been infected. It may help researchers understand protection against future infections.
Hear when a new Mpox (Monkeypox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.